Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis
Abstract Purpose To identify the predictive role of circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) for long-term outcomes in non-small cell lung cancer (NSCLC) patients. Methods Several databases were searched. The primary outcome was progression-free survival (PFS), and the se...
Saved in:
| Main Authors: | Siyuan Che, Dongliang Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | World Journal of Surgical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12957-025-03890-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions
by: Nishanth Thalambedu, et al.
Published: (2025-06-01) -
The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer
by: Brandon Joseph Hebert, et al.
Published: (2024-11-01) -
The role of circulating tumor DNA in melanomas of the uveal tract
by: Mohammed Zeeshan Zameer, et al.
Published: (2024-12-01) -
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
by: Young-gon Kim, et al.
Published: (2024-10-01) -
Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications
by: Dening Ma, et al.
Published: (2025-06-01)